Li Xie

No ORCID on file · 5 papers in corpus · active 2021-2026

Study types

  • article 2
  • preprint 1
  • review 1

Condition tags

  • endometriosis 4
  • infertility 2
article 2026
Gut microbiota-associated immunomodulation contributes to the protective effects of fluvastatin against endometriosis in a mouse model, accompanied by increased Akkermansia muciniphila abundance
Frontiers in microbiology ·doi:10.3389/fmicb.2026.1762444

BACKGROUND: Endometriosis (EMs) is a chronic inflammatory disease characterized by tumor-like growth behavior and limited therapeutic options. Increasing evidence suggests that gut microbiota may contribute to EMs progression by promoting c…

review 2023
Adverse Pregnancy Outcomes Associated with Endometriosis and Its Influencing Factors
Evidence-based complementary and alternative medicine : eCAM ·doi:10.1155/2023/7486220

AIM: To investigate the adverse pregnancy outcomes associated with endometriosis and its influencing factors. METHODS: A total of 188 endometriosis patients who gave birth at our hospital between June 2018 and January 2021 were screened fo…

article 2022
Computational Drug Discovery in Patients with Endometriosis-Induced Infertility via Text Mining and Biomedical Databases
·doi:10.31083/j.ceog4908168

Background: Endometriosis (EMT) is the most common benign gynecological disease among women of reproductive age, causing infertility and seriously affects women’s physical and mental health. However, the current treatment was not always eff…

preprint 2021
Computational Drug Discovery in Patients with Endometriosis-Induced Infertility via Text Mining and Biomedical Databases
·doi:10.21203/rs.3.rs-744890/v1

Abstract Background: Endometriosis (EMT) is the most common benign gynecological disease among women of reproductive age, causing infertility and seriously affects women's physical and mental health. However, the current treatment was not a…

2021
Pyrotinib In The Treatment of Women With Advanced HER2- Positive Breast Cancer: A Multicenter, Prospective, Real-World Study
·doi:10.21203/rs.3.rs-505602/v1

Background: HER2-positive breast cancer was aggressive, resulting in a poorer prognosis. This multicenter study analyzed the real-world data of women treated with pyrotinib-based therapy, aiming to describe their characteristics, treatment…